The medical devices manufacturers industry in the country has welcomed the Central government's decision to withdraw multiple Quality Control Orders (QCOs) imposed on essential raw materials across various industries, including the medical devices sector.
The Association of Indian Medical Device Industry (AiMeD) has welcomed the decision across polymer, plastic, textile, and chemical value chains, and has urged the government to now advance the next reform prioritized in its submissions to the Gauba Committee—the removal of No Objection Certificate (NOC) requirements imposed by various agencies for the import of raw materials, intermediates, and components or reimporting returned export shipments and even at various stages of putting up a green field manufacturing project.
The reversals, notified in the Gazette on November 12, 2025, cover critical inputs such as ABS, polypropylene, polyethylene, polyester fibres and other raw materials widely used by medical device manufacturers. The QCOs that has now been withdrawn covers a wide range of polymer and chemical intermediates that form the backbone of syringes, IV sets, catheters, diagnostic consumables, packaging materials, and other medical devices. India’s domestic supply base does not yet manufacture many of these materials at global specifications, making access to imported grades essential for ensuring product safety, performance, and export readiness, said the organisation. |